Tarsus Pharmaceuticals Inc

NASDAQ:TARS  
29.57
-0.05 (-0.17%)
Products

Tarsus Pharmaceuticals Announces FDA Acceptance Of Investigational Lyme Disease Prevention Drug

Published: 05/04/2021 20:46 GMT
Tarsus Pharmaceuticals Inc (TARS) - Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for Tp-05 for Lyme Disease Prevention.